Business News • MarketWire • Medgenics Announces Exercise by Underwriters of Over-Allotment Option |
Medgenics Announces Exercise by Underwriters of Over-Allotment Option |
|
|
Medgenics Announces Exercise by Underwriters of Over-Allotment Option
MISGAV, ISRAEL and VIENNA, VA--(Marketwire - Apr 19, 2011) - Medgenics, Inc. (NYSE Amex: MDGN) (NYSE Amex: MDGN.W) (AIM: MEDG) (AIM: MEDU), the company that has developed a novel technology for the sustained manufacture and delivery of therapeutic proteins continuously in patients using their own tissue, today announced that, in connection with its previously announced initial public offering in the U.S., the underwriters have exercised their option to purchase additional redeemable Common Stock purchase warrants (the "Warrants") to purchase 369,000 shares of additional Common Stock, $0.0001 par value per share, at the public offering price of $0.46 per Warrant. The Warrants are exercisable at a price of $6.00 each and expire on April 12, 2016. Further details of the Warrants were announced in a press release on April 8, 2011.
View More : http://www.marketwire.com/mw/release.do?id=1504471&sourceType=3
|
|
|